Patient NHS No

Aflibercept for treating visual impairment caused by macular oedema secondary to central retinal vein occlusion [TA409] Commissioning policies. ... Please provide the reasons for each, a copy of the guidance issued and the total annual cost to the CCG of the treatment… ................
................